Michael T. Dill
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Liver physiology and pathology
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
Papers in
- Hepatology 21
- Hepatitis C virus research 14
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Liver physiology and pathology 3
- Oncology 11
- Cytokine Signaling Pathways and Interactions 4
- Co-authors
- Markus H. Heim (17 shared papers)Luigi Terracciano (10 shared papers)Fernando D. Camargo (5 shared papers)Zuzanna Makowska (10 shared papers)Luigi Tornillo (6 shared papers)Mairene Coto‐Llerena (1 shared paper)François H.T. Duong (4 shared papers)David Buechel (1 shared paper)
- Journals
- Hepatology (6 papers)Liver International (4 papers)Gastroenterology (3 papers)Patient Education and Counseling (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Michael T. Dill
38 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Hepatology 729
- Cell Biology 443
- Cancer Research 382
- Epidemiology 575
- Molecular Biology 867
Countries citing papers authored by Michael T. Dill
This map shows the geographic impact of Michael T. Dill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Dill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Dill more than expected).
Fields of papers citing papers by Michael T. Dill
This network shows the impact of papers produced by Michael T. Dill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Dill. The network helps show where Michael T. Dill may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael T. Dill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis Hit paper breakdown → | 2021 | 348 |
| 2 | 2010 | 201 | |
| 3 | 2019 | 177 | |
| 4 | 2015 | 175 | |
| 5 | 2013 | 136 | |
| 6 | 2020 | 125 | |
| 7 | 2018 | 103 | |
| 8 | 2012 | 98 | |
| 9 | 2012 | 94 | |
| 10 | 2011 | 85 | |
| 11 | 1979 | 73 | |
| 12 | 2016 | 56 | |
| 13 | 2018 | 49 | |
| 14 | 2012 | 49 | |
| 15 | 2013 | 49 | |
| 16 | 2014 | 38 | |
| 17 | 2013 | 37 | |
| 18 | 2012 | 35 | |
| 19 | 2013 | 34 | |
| 20 | 2017 | 29 |
About Michael T. Dill
Michael T. Dill is a scholar working on Hepatology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 41 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), interferon and immune responses (6 papers), Hippo pathway signaling and YAP/TAZ (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Hepatitis B Virus Studies (4 papers), Liver physiology and pathology (3 papers) and Hedgehog Signaling Pathway Studies (3 papers). The work is most often cited by research in Hepatology (729 citations), Cell Biology (443 citations), Cancer Research (382 citations), Epidemiology (575 citations) and Molecular Biology (867 citations). Michael T. Dill has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Markus H. Heim, Luigi Terracciano, Fernando D. Camargo, Zuzanna Makowska, Luigi Tornillo, Mairene Coto‐Llerena, François H.T. Duong, David Buechel, Salvatore Piscuoglio and Ravi Kiran Reddy Kalathur. Their work appears in journals such as Hepatology, Liver International, Gastroenterology, Patient Education and Counseling and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.